Amelia Langston, MD
Professor of Hematology and Medical Oncology
Emory School of Medicine
Medical Director and Section Chief
Bone Marrow Transplant Program at the Winship Cancer Institute
Dr. Langston received her BA from Williams College, Williamstown, Massachusetts. She received her MD from Washington University, St. Louis, Missouri. She completed her residency in Internal Medicine at Duke University Medical Center, Durham North Carolina, followed by a Medical Oncology fellowship at the University of Washington Hospitals.
Research Interests
Dr. Langston’s research interests include novel strategies for autologous and allogeneic stem cell transplantation, use of biologically targeted agents for antileukemic therapy, and prevention and treatment of opportunistic infections in immunocompromised patients.
Publications
View publications on PubMed
Clinical Trials
View clinical trials at Winship Cancer Institute
Grants
- Acute Graft-versus-Host Disease Treatment (BMT CTN 0802)
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Dose-Escalation Study
- An Open-Label Extended Use Study of Oral CEP-70
- An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors
- P05615: Pharmacokinetics and Safety of Solid Oral Posaconazole
- A Phase 4 Study Of The Pharmacokinetics Of Oral Posacona
- Phase II Study of Perifosine in Patients With Refractory and Relapsed Leukemia
- A Randomized, Double-Blind, Placebo, Controlled Study To
- Randomized, Open-label Study of Oral CEP-701
- A Randomized, Prospective Trial Comparing the Efficacy of Continuous Subcutaneous Insulin Infusion
- Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
- Trial To Evaluate The Safety, Immunogenicity And Clinica
